NWF Advisory Services’s Novo Nordisk NVO Stock Holding History

NWF Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$310K	Sell	6,476 -718	-10%	-$30.8K	0.03%	306
2026 Q1	$264K	Buy	7,194 +1,103	+18%	+$52.3K	0.03%	317
2025 Q4	$310K	Sell	6,091 -1,046	-15%	-$53.5K	0.03%	280
2025 Q3	$396K	Sell	7,137 -681	-9%	-$39.9K	0.04%	239
2025 Q2	$540K	Buy	+7,818	New	+$532K	0.06%	196
2024 Q4	–	Sell	-3,892	Closed	-$463K	–	377
2024 Q3	$463K	Buy	3,892 +1,758	+82%	+$234K	0.07%	176
2024 Q2	$305K	Buy	2,134 +276	+15%	+$36.6K	0.05%	218
2024 Q1	$239K	Buy	+1,858	New	+$221K	0.04%	257

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

NWF Advisory Services's NVO Position: Q2 2026 in Review

NWF Advisory Services reduced its Novo Nordisk (NVO) stake by 10% in Q2 2026, selling an estimated $30.8K and leaving 6,476 shares worth $310K. The position accounts for 0.03% of the portfolio, ranked #306.

NWF Advisory Services first reported a position in NVO in Q1 2024 and has held it in 8 quarters since. The position peaked at $540K in Q2 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

NWF Advisory Services held 6,476 shares of Novo Nordisk worth $310K as of Q2 2026.
NWF Advisory Services sold 718 Novo Nordisk shares in Q2 2026, an estimated $30.8K.
Novo Nordisk made up 0.03% of NWF Advisory Services's portfolio in Q2 2026, its #306 holding.
NWF Advisory Services first reported a position in Novo Nordisk in Q1 2024 and has held it in 8 quarters since.
NWF Advisory Services's Novo Nordisk position peaked at $540K in Q2 2025.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on NWF Advisory Services's 13F filing for Q2 2026, filed 29 Jul 2026.